Gynäkologische Endokrinologie

, Volume 15, Issue 2, pp 176–180 | Cite as

Neues und praktisch Relevantes aus der gynäkologischen Endokrinologie

Medizin aktuell

New and practically relevant findings in gynecological endocrinology


Einhaltung ethischer Richtlinien


M. von Wolff und P. Stute geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.


  1. 1.
    Irvine K, Laws KR, Gale TM, Kondel TK (2012) Greater cognitive deterioration in women than men with Alzheimer’s disease: a meta analysis. J Clin Exp Neuropsychol 34(9):989–998CrossRefPubMedGoogle Scholar
  2. 2.
    Altmann A, Tian L, Henderson VW, Greicius MD (2014) Alzheimer’s disease neuroimaging initiative I. Sex modifies the APOE-related risk of developing alzheimer disease. Ann Neurol 75(4):563–573CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Epperson CN, Sammel MD, Freeman EW (2013) Menopause effects on verbal memory: findings from a longitudinal community cohort. J Clin Endocrinol Metab 98(9):3829–3838CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Maki PM, Drogos LL, Rubin LH, Banuvar S, Shulman LP, Geller SE (2008) Objective hot flashes are negatively related to verbal memory performance in midlife women. Menopause 15(5):848–856CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Thurston RC, Aizenstein HJ, Derby CA, Sejdic E, Maki PM (2016) Menopausal hot flashes and white matter hyperintensities. Menopause 23(1):27–32CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Henderson VW (2014) Alzheimer’s disease: review of hormone therapy trials and implications for treatment and prevention after menopause. J Steroid Biochem Mol Biol 142:99–106CrossRefPubMedGoogle Scholar
  7. 7.
    Gleason CE, Dowling NM, Wharton W, Manson JE, Miller VM, Atwood CS et al (2015) Effects of hormone therapy on cognition and mood in recently postmenopausal women: findings from the randomized, controlled KEEPS-cognitive and affective study. PLOS Med 12(6):e1001833 (discussion e)CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Espeland MA, Shumaker SA, Leng I, Manson JE, Brown CM, LeBlanc ES et al (2013) Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 years. JAMA Intern Med 173(15):1429–1436CrossRefPubMedGoogle Scholar
  9. 9.
    Guennoun R, Labombarda F, Gonzalez Deniselle MC, Liere P, De Nicola AF, Schumacher M (2015) Progesterone and allopregnanolone in the central nervous system: response to injury and implication for neuroprotection. J Steroid Biochem Mol Biol 146:48–61CrossRefPubMedGoogle Scholar
  10. 10.
    Schumacher M, Denier C, Oudinet JP, Adams D, Guennoun R (2016) Progesterone neuroprotection: the background of clinical trial failure. J Steroid Biochem Mol Biol 160:53–66CrossRefPubMedGoogle Scholar
  11. 11.
    Hitchcock CL, Prior JC (2012) Oral micronized progesterone for vasomotor symptoms--a placebo-controlled randomized trial in healthy postmenopausal women. Menopause 19(8):886–893CrossRefPubMedGoogle Scholar
  12. 12.
    Prior JC, Elliott TG, Norman E, Stajic V, Hitchcock CL (2014) Progesterone therapy, endothelial function and cardiovascular risk factors: a 3-month randomized, placebo-controlled trial in healthy early postmenopausal women. PLOS ONE 9(1):e84698CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Murkes D, Lalitkumar PG, Leifland K, Lundstrom E, Soderqvist G (2012) Percutaneous estradiol/oral micronized progesterone has less-adverse effects and different gene regulations than oral conjugated equine estrogens/medroxyprogesterone acetate in the breasts of healthy women in vivo. Gynecol Endocrinol 28(Suppl 2):12–15CrossRefPubMedGoogle Scholar
  14. 14.
    Conforti A, Alviggi C, Mollo A et al (2013) The management of Asherman syndrome: a review of literature. Reprod Biol Endocrinol 11:118CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Cervelló I, Gil-Sanchis C, Mas A et al (2010) Human endometrial side population cells exhibit genotypic, phenotypic and functional features of somatic stem cells. PLOS ONE 5:e10964CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Santamaria X, Cabanillas S, Cervelló I et al (2016) Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman’s syndrome and endometrial atrophy: a pilot cohort study. Hum Reprod 31:1087–1096CrossRefPubMedGoogle Scholar
  17. 17.
    Mikkola TS, Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P et al (2015) Increased cardiovascular mortality risk in women discontinuing postmenopausal hormone therapy. J Clin Endocrinol Metab 100(12):4588–4594CrossRefPubMedGoogle Scholar
  18. 18.
    Mosher W, Jones J, Abma J (2015) Nonuse of contraception among women at risk of unintended pregnancy in the United States. Contraception 92(2):170–176CrossRefPubMedGoogle Scholar
  19. 19.
    Al-Hassan N (2011) Guidance on contraception for women aged over 40 years. J Fam Plann Reprod Health Care 37(2):124–125 (discussion 5)CrossRefPubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH 2017

Authors and Affiliations

  1. 1.Abteilung für Gynäkologische Endokrinologie und ReproduktionsmedizinUniversitäts-Frauenklinik, Inselspital BernBernSchweiz

Personalised recommendations